All News
Dr. Zuily, Dr. Barbhaiya, and Dr. Erkan presented today at #ACR19 results of phase 2 of the development of New Classification Criteria for #APS. They also commented that phase 3 is ongoing. https://t.co/B6g4SJ3CzU https://t.co/xTLXFh2Fg6
EMEUNET EMEUNET ( View Tweet)
Mike Lee tells us the complex differential Dx of fleeting blindness- GCA is but one Dx @MdWarrington @hajj@ #ACR19 https://t.co/Px6AApAiQU
Leonard Calabrese LCalabreseDO ( View Tweet)
Nice to meet you at the Tweet up @LCalabreseDO @CCalabreseDO.. you missed the photo but not the salute with the friends 🙋 @ClevelandClinic 🏥 #ACR19 #Atlanta su amigo de México! https://t.co/5vtwWIDDpo
Dr.Martínez MtzReuma ( View Tweet)
SSc gut has poor QoL. Study shows more severe symptoms are associated with worse pathology. So believe the pts and treat what you can. High dose PPIs, promotility drugs, antibiotics for SIBO, laxatives for constipation and Rx for diarrhea. #ACR2019 @RheumNow Abst735 https://t.co/xcFrXXazql
Janet Pope Janetbirdope ( View Tweet)
Actually 30 days is still a great window for TA bx. By me. https://t.co/6H5NziUA0G
Leonard Calabrese LCalabreseDO ( View Tweet)
🌞 " I am not discouraged because every wrong attempt discarded is another step forward.” - Thomas Edison
The future is bright! - Dr. Manzi
#ACR19 @RheumNow
Kanika Monga, MD DrKanikaMonga ( View Tweet)
Woo hoo! @rheum_cat and her poster on CV disease risk in aXSpA abstr #622 #ACR19 https://t.co/eaDyCKZs5J
Kanika Monga, MD DrKanikaMonga ( View Tweet)
Every women with lupus can find an effective contraceptive method.
Do you feel comfortable counselling your lupus patients about their contraceptive options. #ACR19 @RheumNow
Maeve Gamble MaeveGamble ( View Tweet)
Upadacitinib as monotherapy vs MTX. Wk48 results are consistent & good!
#ACR19 @rheumnow Abst0928 #ACRbest https://t.co/lmAMF3HqoI
Dr Irwin Lim _connectedcare ( View Tweet)
Upadacitinib monotherapy vs MTX. Safety data at wk48
#ACR19 @rheumnow Abst0928 https://t.co/P3La0rO9Nl
Dr Irwin Lim _connectedcare ( View Tweet)
Fenebrutinib wk12 results for both cohorts. Does not look better than ADA (secondary endpoint)
#ACR19 @rheumnow Abst0929 https://t.co/vIygXGn4vT
Dr Irwin Lim _connectedcare ( View Tweet)
One thing that Dan Clauw pointed out in his #fibromyalgia talk was that legalising cannabis in a state leads to dramatic reductions in opioid overdoses, in some cases showing reductions of >40% sustained for years.
#ACR19 @Rheumnow Ref -> https://t.co/buRPCqeR2A
Philip Robinson philipcrobinson ( View Tweet)
Great resource for rheumatic medications and breastfeeding. https://t.co/U88I6MmJDT #ACR19 @RheumNow #pregnancy
Maeve Gamble MaeveGamble ( View Tweet)
How to switch from MMF to AZA for pregnancy:
#ACR19 @rheumnow #pregnancy #lupus https://t.co/er4CvIkOBQ
Maeve Gamble MaeveGamble ( View Tweet)
A small New Zealand study (n=50) gave different doses of tart cherry concentrate and assessed its effect on serum urate over 28 days. No effect was found. We shouldn't be emphasising dietary changes in gout patients - no evidence of efficacy #ACR19 @RheumNow #gout https://t.co/OamMPMHw0C
Philip Robinson philipcrobinson ( View Tweet)
Abstr#548: Efficacy and safety of subcut CT-P13 (IFX biosimilar) 1 year after switching from IV CT-P13 in pts with RA. Non-inferiority of efficacy (decrease in baseline DAS28-CRP) at wk 22 achieved. Safety same. Another alt convenient way of administration? #ACR2019 @RheumNow
Maeve Gamble MaeveGamble ( View Tweet)
Basic truths of irAEs:
Symptoms do not equal irAEs, in diarrhoea/colitis as in arthralgias/arthritis. Substantial proportion excluded on investigation
Local site Rx where possible: because they often work, and systemic steroids still can’t be exonerated
#ACR19 @RheumNow https://t.co/TJHQkKcvX8
David Liew drdavidliew ( View Tweet)
Normal inflamm markers in PMR: 14% (62/454) of the Nijmegen PMR cohort fell in this group, and they had similar rates of follow-up, steroid dependence, even similar rates of GCA (albeit low). A subgroup of PMR we need to understand better!
Diane Marsman #ACR19 ABST0759 @RheumNow https://t.co/XS2bPrWKUf
David Liew drdavidliew ( View Tweet)
One of the hardest things about PMR is getting a reliable diagnosis - no biomarker and no histopath. Imaging has potential, and my colleague @drceowen has made a simple algorithm for reliable/replicable PET/CT dx 👍
@DrCMcMaster @jlyleung @Austin_Health #ACR19 ABST0755 @RheumNow https://t.co/JGswa6Wjju
David Liew drdavidliew ( View Tweet)
The C-AxSpand study, Certolizumab-treated nr-axSpA pts with shorter symptom duration (< 5 vs ≥ 5 years) showed greater improvements across signs and symptoms of disease and in quality of life. Kay J et al #ACR19 @RheumNow
Dr. Antoni Chan synovialjoints ( View Tweet)
